You're the one who who was speculating, causing him to comment. For all we know, they applied for both at the same time or the Androgenetic Alopecia one first and it got rejected due to the phase 1 structure or something that the FDA/Australian government didn't like in the trial design. You're the one that said they prioritize it less, which is something we absolutely don't know.The only thing clear is that treating hairloss is not on the top of their priorities list, as per the clinical trials they started with the focus of another disease — and probably because of the reasons you stated. The rest is us speculating.